Louis Todd Borgmann - 21 Nov 2024 Form 4 Insider Report for Calumet, Inc. /DE (CLMT)

Role: CHIEF EXECUTIVE OFFICER
Signature: /s/ Todd Borgmann
Issuer symbol: CLMT
Transactions as of: 21 Nov 2024
Net transactions value: -$34,200
Form type: 4
Filing time: 25 Nov 2024, 21:49:21 UTC
Previous filing: 08 Apr 2024
Next filing: 27 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLMT	Common Stock, par value $0.01 per share	Award	$217,800	+10,000	+6.2%	$21.78	171,413	22 Nov 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLMT	Call Option (right to buy)	Sale	$252,000	-900	-100%	$280.00^*	0	21 Nov 2024	Common Stock, par value $0.01 per share	90,000	$20.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 21, 2024, the reporting person sold 900 call options, which were options to buy 90,000 shares of Calumet, Inc. common stock, at an exercise price of $20 per share and with an expiration date of January 17, 2025. The reporting person received total proceeds of $252,003 from the sale of the call options, of which $217,800 was used to fund the purchase of 10,000 shares of Calumet, Inc. common stock reported herein, and the remaining proceeds are intended to satisfy certain tax obligations that were incurred in connection with the sale of the call options.

Content

On November 21, 2024, the reporting person sold 900 call options, which were options to buy 90,000 shares of Calumet, Inc. common stock, at an exercise price of $20 per share and with an expiration date of January 17, 2025. The reporting person received total proceeds of $252,003 from the sale of the call options, of which $217,800 was used to fund the purchase of 10,000 shares of Calumet, Inc. common stock reported herein, and the remaining proceeds are intended to satisfy certain tax obligations that were incurred in connection with the sale of the call options.